$SGEN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Seagen Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Seagen Inc.. Get notifications about new insider transactions in Seagen Inc. for free.
Page: < prev 1 2 3 4 5 6 ... 33 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Option Exercise | M | 15.46 | 3,590 | 55,501 | 244,136 | |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Option Exercise | M | 15.46 | 1,741 | 26,916 | 247,726 | |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Option Exercise | M | 15.46 | 1,080 | 16,697 | 249,467 | |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Option Exercise | M | 15.46 | 14,908 | 230,478 | 250,547 | |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Option Exercise | M | 15.46 | 6,824 | 105,499 | 265,455 | |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Sell | S | 182.97 | 904 | 165,405 | 715,209 | 716.1 K to 715.2 K (-0.13 %) |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Buy | M | 15.46 | 904 | 13,976 | 716,113 | 715.2 K to 716.1 K (+0.13 %) |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Sell | S | 182.49 | 5,056 | 922,669 | 715,209 | 720.3 K to 715.2 K (-0.70 %) |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Buy | M | 15.46 | 5,056 | 78,166 | 720,265 | 715.2 K to 720.3 K (+0.71 %) |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Sell | S | 181.38 | 3,352 | 607,986 | 715,209 | 718.6 K to 715.2 K (-0.47 %) |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Buy | M | 15.46 | 3,352 | 51,822 | 718,561 | 715.2 K to 718.6 K (+0.47 %) |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Sell | S | 180.25 | 3,590 | 647,098 | 715,209 | 718.8 K to 715.2 K (-0.50 %) |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Buy | M | 15.46 | 3,590 | 55,501 | 718,799 | 715.2 K to 718.8 K (+0.50 %) |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Sell | S | 179.40 | 1,741 | 312,335 | 715,209 | 717 K to 715.2 K (-0.24 %) |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Buy | M | 15.46 | 1,741 | 26,916 | 716,950 | 715.2 K to 717 K (+0.24 %) |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Sell | S | 178.36 | 1,080 | 192,629 | 715,209 | 716.3 K to 715.2 K (-0.15 %) |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Buy | M | 15.46 | 1,080 | 16,697 | 716,289 | 715.2 K to 716.3 K (+0.15 %) |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Sell | S | 179.17 | 14,908 | 2,671,066 | 715,209 | 730.1 K to 715.2 K (-2.04 %) |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Buy | M | 15.46 | 14,908 | 230,478 | 730,117 | 715.2 K to 730.1 K (+2.08 %) |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Sell | S | 180.00 | 6,824 | 1,228,320 | 715,209 | 722 K to 715.2 K (-0.95 %) |
| Dec 08 2020 | SGEN | Seagen Inc. | SIEGALL CLAY B | President and CEO | Buy | M | 15.46 | 6,824 | 105,499 | 722,033 | 715.2 K to 722 K (+0.95 %) |
| Dec 03 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Option Exercise | M | 39.15 | 7,666 | 300,124 | 0 | |
| Dec 03 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Option Exercise | M | 39.15 | 6,000 | 234,900 | 7,666 | |
| Dec 03 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Sell | S | 179.30 | 7,666 | 1,374,514 | 44,077 | 51.7 K to 44.1 K (-14.82 %) |
| Dec 03 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Buy | M | 39.15 | 7,666 | 300,124 | 51,743 | 44.1 K to 51.7 K (+17.39 %) |
| Dec 03 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Sell | S | 179.09 | 6,000 | 1,074,539 | 44,077 | 50.1 K to 44.1 K (-11.98 %) |
| Dec 03 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Buy | M | 39.15 | 6,000 | 234,900 | 50,077 | 44.1 K to 50.1 K (+13.61 %) |
| Nov 23 2020 | SGEN | Seagen Inc. | GRYSKA DAVID W | Director | Option Exercise | M | 19.02 | 7,871 | 149,706 | 0 | |
| Nov 23 2020 | SGEN | Seagen Inc. | GRYSKA DAVID W | Director | Option Exercise | M | 19.02 | 7,129 | 135,594 | 7,871 | |
| Nov 23 2020 | SGEN | Seagen Inc. | GRYSKA DAVID W | Director | Sell | S | 173.25 | 7,871 | 1,363,651 | 44,848 | 52.7 K to 44.8 K (-14.93 %) |
| Nov 23 2020 | SGEN | Seagen Inc. | GRYSKA DAVID W | Director | Buy | M | 19.02 | 7,871 | 149,706 | 52,719 | 44.8 K to 52.7 K (+17.55 %) |
| Nov 23 2020 | SGEN | Seagen Inc. | GRYSKA DAVID W | Director | Sell | S | 174.20 | 7,129 | 1,241,872 | 44,848 | 52 K to 44.8 K (-13.72 %) |
| Nov 23 2020 | SGEN | Seagen Inc. | GRYSKA DAVID W | Director | Buy | M | 19.02 | 7,129 | 135,594 | 51,977 | 44.8 K to 52 K (+15.90 %) |
| Nov 06 2020 | SGEN | Seagen Inc. | GRYSKA DAVID W | Director | Sell | S | 180.60 | 4,500 | 812,699 | 44,848 | 49.3 K to 44.8 K (-9.12 %) |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Option Exercise | M | 44.09 | 5,151 | 227,108 | 0 | |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Option Exercise | M | 34.20 | 1,590 | 54,378 | 3,179 | |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Option Exercise | M | 45.30 | 2,207 | 99,977 | 0 | |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Option Exercise | M | 44.09 | 1,276 | 56,259 | 0 | |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Option Exercise | M | 41.04 | 1,218 | 49,987 | 0 | |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Option Exercise | M | 39.15 | 2,220 | 86,913 | 0 | |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Option Exercise | M | 31.37 | 417 | 13,081 | 0 | |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Sell | S | 178.63 | 1,218 | 217,571 | 44,077 | 45.3 K to 44.1 K (-2.69 %) |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Buy | M | 41.04 | 1,218 | 49,987 | 45,295 | 44.1 K to 45.3 K (+2.76 %) |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Sell | S | 178.68 | 1,276 | 227,996 | 44,077 | 45.4 K to 44.1 K (-2.81 %) |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Buy | M | 44.09 | 1,276 | 56,259 | 45,353 | 44.1 K to 45.4 K (+2.89 %) |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Sell | S | 178.63 | 5,151 | 920,123 | 44,077 | 49.2 K to 44.1 K (-10.46 %) |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Buy | M | 44.09 | 5,151 | 227,108 | 49,228 | 44.1 K to 49.2 K (+11.69 %) |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Sell | S | 182.44 | 417 | 76,077 | 44,077 | 44.5 K to 44.1 K (-0.94 %) |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Buy | M | 31.37 | 417 | 13,081 | 44,494 | 44.1 K to 44.5 K (+0.95 %) |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Sell | S | 182.45 | 2,220 | 405,039 | 44,077 | 46.3 K to 44.1 K (-4.80 %) |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Buy | M | 39.15 | 2,220 | 86,913 | 46,297 | 44.1 K to 46.3 K (+5.04 %) |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Sell | S | 182.44 | 2,207 | 402,645 | 44,077 | 46.3 K to 44.1 K (-4.77 %) |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Buy | M | 45.30 | 2,207 | 99,977 | 46,284 | 44.1 K to 46.3 K (+5.01 %) |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Sell | S | 182.37 | 1,590 | 289,968 | 44,077 | 45.7 K to 44.1 K (-3.48 %) |
| Nov 06 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Buy | M | 34.20 | 1,590 | 54,378 | 45,667 | 44.1 K to 45.7 K (+3.61 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | DANSEY ROGER D | Chief Medical Offic ... | Sell | S | 177.07 | 359 | 63,566 | 110,221 | 110.6 K to 110.2 K (-0.32 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | DANSEY ROGER D | Chief Medical Offic ... | Sell | S | 177.00 | 7,302 | 1,292,454 | 110,580 | 117.9 K to 110.6 K (-6.19 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 56.77 | 9,260 | 525,690 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 39.94 | 9,260 | 369,844 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 38.82 | 9,260 | 359,473 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 36.70 | 8,750 | 321,125 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | DANSEY ROGER D | Chief Medical Offic ... | Sell | S | 177.07 | 359 | 63,566 | 110,221 | 110.6 K to 110.2 K (-0.32 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 34.25 | 8,750 | 299,688 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | DANSEY ROGER D | Chief Medical Offic ... | Sell | S | 177.00 | 7,302 | 1,292,454 | 110,580 | 117.9 K to 110.6 K (-6.19 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 20.06 | 12,784 | 256,447 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 20.06 | 4,716 | 94,603 | 12,784 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 169.80 | 14,064 | 2,388,067 | 52,338 | 66.4 K to 52.3 K (-21.18 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.89 | 65,246 | 11,019,397 | 66,402 | 131.6 K to 66.4 K (-49.56 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 167.10 | 12,784 | 2,136,206 | 131,648 | 144.4 K to 131.6 K (-8.85 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 20.06 | 12,784 | 256,447 | 144,432 | 131.6 K to 144.4 K (+9.71 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 167.97 | 4,716 | 792,147 | 131,648 | 136.4 K to 131.6 K (-3.46 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 20.06 | 4,716 | 94,603 | 136,364 | 131.6 K to 136.4 K (+3.58 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.11 | 8,750 | 1,470,963 | 131,648 | 140.4 K to 131.6 K (-6.23 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 36.70 | 8,750 | 321,125 | 140,398 | 131.6 K to 140.4 K (+6.65 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.32 | 8,750 | 1,472,800 | 131,648 | 140.4 K to 131.6 K (-6.23 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 34.25 | 8,750 | 299,688 | 140,398 | 131.6 K to 140.4 K (+6.65 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.39 | 9,260 | 1,559,291 | 131,648 | 140.9 K to 131.6 K (-6.57 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 39.94 | 9,260 | 369,844 | 140,908 | 131.6 K to 140.9 K (+7.03 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.42 | 9,260 | 1,559,569 | 131,648 | 140.9 K to 131.6 K (-6.57 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 38.82 | 9,260 | 359,473 | 140,908 | 131.6 K to 140.9 K (+7.03 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.45 | 9,260 | 1,559,847 | 131,648 | 140.9 K to 131.6 K (-6.57 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 56.77 | 9,260 | 525,690 | 140,908 | 131.6 K to 140.9 K (+7.03 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 56.77 | 9,260 | 525,690 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 39.94 | 9,260 | 369,844 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 38.82 | 9,260 | 359,473 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 36.70 | 8,750 | 321,125 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 34.25 | 8,750 | 299,688 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 20.06 | 12,784 | 256,447 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 20.06 | 4,716 | 94,603 | 12,784 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 169.80 | 14,064 | 2,388,067 | 52,338 | 66.4 K to 52.3 K (-21.18 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.89 | 65,246 | 11,019,397 | 66,402 | 131.6 K to 66.4 K (-49.56 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 167.10 | 12,784 | 2,136,206 | 131,648 | 144.4 K to 131.6 K (-8.85 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 20.06 | 12,784 | 256,447 | 144,432 | 131.6 K to 144.4 K (+9.71 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 167.97 | 4,716 | 792,147 | 131,648 | 136.4 K to 131.6 K (-3.46 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 20.06 | 4,716 | 94,603 | 136,364 | 131.6 K to 136.4 K (+3.58 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.11 | 8,750 | 1,470,963 | 131,648 | 140.4 K to 131.6 K (-6.23 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 36.70 | 8,750 | 321,125 | 140,398 | 131.6 K to 140.4 K (+6.65 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.32 | 8,750 | 1,472,800 | 131,648 | 140.4 K to 131.6 K (-6.23 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 34.25 | 8,750 | 299,688 | 140,398 | 131.6 K to 140.4 K (+6.65 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.39 | 9,260 | 1,559,291 | 131,648 | 140.9 K to 131.6 K (-6.57 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 39.94 | 9,260 | 369,844 | 140,908 | 131.6 K to 140.9 K (+7.03 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.42 | 9,260 | 1,559,569 | 131,648 | 140.9 K to 131.6 K (-6.57 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 38.82 | 9,260 | 359,473 | 140,908 | 131.6 K to 140.9 K (+7.03 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.45 | 9,260 | 1,559,847 | 131,648 | 140.9 K to 131.6 K (-6.57 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 56.77 | 9,260 | 525,690 | 140,908 | 131.6 K to 140.9 K (+7.03 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Option Exercise | M | 26.10 | 1,620 | 42,282 | 0 | |
| Nov 04 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Option Exercise | M | 18.46 | 799 | 14,750 | 0 | |
| Nov 04 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Option Exercise | M | 15.46 | 2,778 | 42,948 | 0 | |
| Nov 04 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Sell | S | 169.51 | 864 | 146,457 | 44,077 | 44.9 K to 44.1 K (-1.92 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Sell | S | 172.50 | 2,778 | 479,205 | 44,941 | 47.7 K to 44.9 K (-5.82 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Buy | M | 15.46 | 2,778 | 42,948 | 47,719 | 44.9 K to 47.7 K (+6.18 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Sell | S | 172.50 | 799 | 137,828 | 44,941 | 45.7 K to 44.9 K (-1.75 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Buy | M | 18.46 | 799 | 14,750 | 45,740 | 44.9 K to 45.7 K (+1.78 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Sell | S | 172.50 | 1,620 | 279,450 | 44,941 | 46.6 K to 44.9 K (-3.48 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Buy | M | 26.10 | 1,620 | 42,282 | 46,561 | 44.9 K to 46.6 K (+3.60 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Sell | S | 166.00 | 7,468 | 1,239,692 | 44,941 | 52.4 K to 44.9 K (-14.25 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | ROMP CHARLES R | EVP, Commercial | Sell | S | 167.80 | 5,533 | 928,437 | 52,409 | 57.9 K to 52.4 K (-9.55 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Option Exercise | M | 36.70 | 8,750 | 321,125 | 0 | |
| Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Option Exercise | M | 34.25 | 8,750 | 299,688 | 0 | |
| Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Option Exercise | M | 20.06 | 9,518 | 190,931 | 0 | |
| Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Option Exercise | M | 20.06 | 7,982 | 160,119 | 9,518 | |
| Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Option Exercise | M | 19.02 | 14,500 | 275,790 | 0 | |
| Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Sell | S | 164.61 | 9,250 | 1,522,643 | 47,348 | 56.6 K to 47.3 K (-16.34 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Sell | S | 165.06 | 14,500 | 2,393,370 | 56,598 | 71.1 K to 56.6 K (-20.39 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Buy | M | 19.02 | 14,500 | 275,790 | 71,098 | 56.6 K to 71.1 K (+25.62 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Sell | S | 165.72 | 9,518 | 1,577,323 | 56,598 | 66.1 K to 56.6 K (-14.40 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Buy | M | 20.06 | 9,518 | 190,931 | 66,116 | 56.6 K to 66.1 K (+16.82 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Sell | S | 166.70 | 7,982 | 1,330,599 | 56,598 | 64.6 K to 56.6 K (-12.36 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Buy | M | 20.06 | 7,982 | 160,119 | 64,580 | 56.6 K to 64.6 K (+14.10 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Sell | S | 167.34 | 8,750 | 1,464,225 | 56,598 | 65.3 K to 56.6 K (-13.39 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Buy | M | 36.70 | 8,750 | 321,125 | 65,348 | 56.6 K to 65.3 K (+15.46 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Sell | S | 168.24 | 8,750 | 1,472,100 | 56,598 | 65.3 K to 56.6 K (-13.39 %) |
| Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Buy | M | 34.25 | 8,750 | 299,688 | 65,348 | 56.6 K to 65.3 K (+15.46 %) |
| Sep 23 2020 | SGEN | SEATTLE GENETICS I ... | LIU JEAN I | GC/EVP, Leg Affairs | Option Exercise | M | 39.15 | 2,554 | 99,989 | 0 | |
| Sep 23 2020 | SGEN | SEATTLE GENETICS I ... | LIU JEAN I | GC/EVP, Leg Affairs | Option Exercise | M | 35.95 | 7,400 | 266,030 | 3,724 | |
| Sep 23 2020 | SGEN | SEATTLE GENETICS I ... | LIU JEAN I | GC/EVP, Leg Affairs | Buy | M | 35.95 | 7,400 | 266,030 | 58,642 | 51.2 K to 58.6 K (+14.44 %) |
| Sep 23 2020 | SGEN | SEATTLE GENETICS I ... | LIU JEAN I | GC/EVP, Leg Affairs | Buy | M | 39.15 | 2,554 | 99,989 | 51,242 | 48.7 K to 51.2 K (+5.25 %) |
| Sep 16 2020 | SGEN | SEATTLE GENETICS I ... | LIU JEAN I | GC/EVP, Leg Affairs | Sell | S | 170.00 | 11,610 | 1,973,700 | 48,688 | 60.3 K to 48.7 K (-19.25 %) |
| Sep 11 2020 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Option Exercise | M | 15.46 | 8,000 | 123,680 | 30,697 | |
| Sep 11 2020 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Sell | S | 148.31 | 734 | 108,860 | 186,829 | 187.6 K to 186.8 K (-0.39 %) |
| Sep 11 2020 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Sell | S | 147.86 | 4,766 | 704,701 | 187,563 | 192.3 K to 187.6 K (-2.48 %) |
| Sep 11 2020 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Sell | S | 146.73 | 2,500 | 366,825 | 192,329 | 194.8 K to 192.3 K (-1.28 %) |
| Sep 11 2020 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Buy | M | 15.46 | 8,000 | 123,680 | 194,829 | 186.8 K to 194.8 K (+4.28 %) |
| Sep 02 2020 | SGEN | SEATTLE GENETICS I ... | DANSEY ROGER D | Chief Medical Offic ... | Sell | S | 155.69 | 169 | 26,312 | 117,882 | 118.1 K to 117.9 K (-0.14 %) |
| Sep 02 2020 | SGEN | SEATTLE GENETICS I ... | DANSEY ROGER D | Chief Medical Offic ... | Sell | S | 155.69 | 741 | 115,369 | 118,051 | 118.8 K to 118.1 K (-0.62 %) |
| Sep 02 2020 | SGEN | SEATTLE GENETICS I ... | DANSEY ROGER D | Chief Medical Offic ... | Sell | S | 155.69 | 3,701 | 576,224 | 118,792 | 122.5 K to 118.8 K (-3.02 %) |
| Sep 02 2020 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Sell | S | 155.69 | 1,796 | 279,627 | 186,829 | 188.6 K to 186.8 K (-0.95 %) |
| Sep 02 2020 | SGEN | SEATTLE GENETICS I ... | HIMES VAUGHN B | Chief Technical Off ... | Sell | S | 155.69 | 1,789 | 278,537 | 188,625 | 190.4 K to 188.6 K (-0.94 %) |
| Sep 02 2020 | SGEN | SEATTLE GENETICS I ... | LIU JEAN I | GC/EVP, Leg Affairs | Sell | S | 155.69 | 1,893 | 294,729 | 60,298 | 62.2 K to 60.3 K (-3.04 %) |
| Sep 02 2020 | SGEN | SEATTLE GENETICS I ... | LIU JEAN I | GC/EVP, Leg Affairs | Sell | S | 155.69 | 1,755 | 273,243 | 62,191 | 63.9 K to 62.2 K (-2.74 %) |